These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25359383)
41. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome. Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561 [TBL] [Abstract][Full Text] [Related]
42. Antiphospholipid antibody profile: implications for the evaluation and management of patients. Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983 [TBL] [Abstract][Full Text] [Related]
43. Precision medicine and the antiphospholipid syndrome: what is the future? Rodriguez-Pintó I; Espinosa G; Cervera R Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811 [No Abstract] [Full Text] [Related]
44. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome. Lutters BC; de Groot PG; Derksen RH Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190 [No Abstract] [Full Text] [Related]
49. Autoantibodies directed against domain I of beta2-glycoprotein I. de Laat B; de Groot PG Curr Rheumatol Rep; 2011 Feb; 13(1):70-6. PubMed ID: 21046294 [TBL] [Abstract][Full Text] [Related]
50. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. Akhter E; Shums Z; Norman GL; Binder W; Fang H; Petri M J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459 [TBL] [Abstract][Full Text] [Related]
51. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158 [TBL] [Abstract][Full Text] [Related]
52. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B Lupus; 1998; 7(2):124-31. PubMed ID: 9541097 [TBL] [Abstract][Full Text] [Related]
53. [Experts consensus on clinical application of antiphospholipid antibodies detection]. ; ; Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):496-500. PubMed ID: 31269565 [TBL] [Abstract][Full Text] [Related]
54. Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. Andreoli L; Fredi M; Nalli C; Piantoni S; Reggia R; Dall'Ara F; Franceschini F; Tincani A Curr Rheumatol Rep; 2013 Jul; 15(7):343. PubMed ID: 23754504 [TBL] [Abstract][Full Text] [Related]
55. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478 [TBL] [Abstract][Full Text] [Related]
56. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus]. Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352 [TBL] [Abstract][Full Text] [Related]
57. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Bertolaccini ML; Amengual O; Andreoli L; Atsumi T; Chighizola CB; Forastiero R; de Groot P; Lakos G; Lambert M; Meroni P; Ortel TL; Petri M; Rahman A; Roubey R; Sciascia S; Snyder M; Tebo AE; Tincani A; Willis R Autoimmun Rev; 2014 Sep; 13(9):917-30. PubMed ID: 24824074 [TBL] [Abstract][Full Text] [Related]
58. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome. Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG Lupus; 1999; 8(3):234-9. PubMed ID: 10342717 [TBL] [Abstract][Full Text] [Related]
59. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related]
60. Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation. Albay A; Artim-Esen B; Pericleous C; Wincup C; Giles I; Rahman A; McDonnell T Lupus; 2019 Jun; 28(7):893-897. PubMed ID: 31126213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]